Tilray Brands (TLRY), a cannabis company, will release its Q1 FY26 results on October 9. The penny stock has surged 189% over the past three months, fueled by optimism around potential regulatory changes in the U.S. cannabis market. Even so, the stock is still down about 2% over the past year, weighed down by ongoing losses, slow revenue growth, and persistent challenges in the cannabis sector.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Wall Street analysts expect Tilray Brands to report a loss per share of $0.03, versus a loss of $0.04 per share in the year-ago quarter. Meanwhile, revenues are expected to increase modestly by 2% from the year-ago quarter to $204.6 million, according to data from the TipRanks Forecast page. It’s important to note that Tilray Brands has missed EPS estimates in all of the past nine quarters.
Jefferies Ups Price Target on TLRY
In August, Jefferies analyst Kaumil Gajrawala raised his price target on Tilray from $1.50 to $2 while maintaining a Buy rating. He pointed out that recent comments from President Trump about reclassifying marijuana from Schedule I to Schedule III could act as a key tailwind for the sector.
Gajrawala added that Tilray’s strong brands, growing scale, and solid balance sheet position the company well to benefit if policy changes move forward.
Options Traders Anticipate a Large Move
Using TipRanks’ Options tool, we can see what options traders are expecting from the stock immediately after its earnings report. The expected earnings move is determined by calculating the at-the-money straddle of the options closest to expiration after the earnings announcement. If this sounds complicated, don’t worry, the Options tool does this for you.
Indeed, it currently says that options traders are expecting a 21.05% move in either direction.
Is Tilray a Good Stock to Buy Now?
Turning to Wall Street, TLRY stock has a Moderate Buy consensus rating based on two Buys and three Hold ratings assigned in the last three months. At $1.03, the average Tilray price target implies 39.77% downside potential.
